Tumor Necrosis Factor Inhibitors as Early Steroid-Sparing Therapy for Neurosarcoidosis: A Case Series

From the ∗Department of Medicine, University of Vermont Medical Center

†Department of Neurological Sciences

‡Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Vermont Medical Center and Robert Larner MD College of Medicine at the University of Vermont, Burlington, VT.

The authors declare no conflict of interest.

Correspondence: Tessalyn Morrison, MD, MPH, Department of Internal Medicine, University of Vermont Medical Center, 111 Colchester Ave, Burlington, VT 05401. E-mail: [email protected].

留言 (0)

沒有登入
gif